LONGEVITY & CELLULAR HEALTH / FAQ
Questions From the Literature
Direct, citation-anchored answers to the questions readers most often bring to NAD+ and MOTS-c.
What is NAD supplement used for?
In research and supplement contexts, NAD+ precursors — chiefly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — are studied for their ability to raise circulating and tissue NAD+ levels, which decline with age. The rationale is that restoring NAD+ availability could support the sirtuins and PARP enzymes that depend on it for DNA repair and gene regulation [4]. Human RCTs have confirmed blood NAD+ elevation [2][5] and one controlled trial found improved muscle insulin sensitivity in prediabetic women [3]. Translation to hard clinical outcomes — longevity, disease prevention — has not been established as of a 2025 review [1]. This site describes the research and gives no medical advice.
What is the downside of taking NAD+?
Several concerns appear in the peer-reviewed record. First, plain oral "NAD+" capsules are widely sold but the intact molecule is poorly absorbed into cells; most researchers consider oral NMN or NR the rational precursor approach [1]. IV NAD+ infusions — administered in wellness clinics — can cause chest or abdominal discomfort, flushing, and nausea if given too quickly, and one compounded injectable was recalled by the FDA at the Class I level for elevated bacterial endotoxin [1]. Theoretically, boosting NAD+ could fuel the metabolism of existing cancers, given NAD+'s role in supporting proliferating cells; this is an open question the research community has flagged [4]. Supplement-grade products vary in purity, and the regulatory status of NMN has been contested by the FDA.
Is it safe to take NAD daily?
Within the formal clinical trials, oral NMN and NR have shown favorable short-term safety profiles. NMN at 300-900 mg/day for 60 days in healthy middle-aged adults produced no safety concerns [2], and NR at 100-1000 mg/day for 8 weeks showed no significant adverse events versus placebo, with no LDL elevation or 1-carbon metabolism disruption [5]. However, these are 8-to-12-week trials in selected populations; long-term safety data in diverse human populations are not available. This site provides no dosing advice, and readers considering any supplement or IV therapy should consult a licensed clinician.
Does NAD cause weight gain?
The published clinical trials do not report weight gain as an outcome of NMN or NR supplementation. NMN at 250 mg/day for 10 weeks in prediabetic women improved insulin sensitivity without changing body composition [3], and NR studies across doses found no significant adverse metabolic effects including weight change versus placebo [5]. NAD+ is involved in energy metabolism generally, but the controlled evidence does not associate oral precursor supplementation with weight gain. This site does not advise on use, and any questions about metabolic effects in a specific individual belong to a licensed clinician.
What does the MOTS-c peptide do?
MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome. Its best-characterized action is inhibiting the folate cycle and de novo purine biosynthesis, which raises AICAR and activates AMPK — the master metabolic regulator — improving glucose handling and insulin sensitivity primarily in skeletal muscle [10]. A 2024 study identified casein kinase 2 (CK2) as a direct binding target, with tissue-specific CK2 modulation in muscle and fat driving its metabolic effects [8]. Under stress, MOTS-c translocates to the cell nucleus and regulates gene expression including antioxidant-response-element genes [12]. Exercise induces endogenous MOTS-c expression, and exogenous MOTS-c enhanced physical performance in aged mice [11]. There are no human interventional trials of exogenous MOTS-c.
What are the negative side effects of MOTS-c?
Because no human clinical trials of exogenous MOTS-c have been completed, a reliable human side-effect profile does not exist. The published literature identifies several cautions: no human pharmacokinetics data (so dose, bioavailability, and safety window are unknown); research-grade supply chains that are not regulated for purity or sterility; and a prohibition in elite sport, where use can result in sanctions [10]. A mitochondrial DNA variant affecting MOTS-c (m.1382A>C) is associated with impaired glycemic response, suggesting effects are not uniform across populations. This site does not advise on use and cannot characterize risks for any individual.
Is MOTS-c legal to buy?
MOTS-c is sold by chemical research suppliers for laboratory and research use only. It is not an approved drug or dietary supplement in the United States or any major jurisdiction, and it is not legal to purchase for human consumption or therapeutic use. For athletes in governed sport, MOTS-c is treated as a prohibited substance by WADA under hormone and metabolic-modulator categories — purchasing or using it could result in anti-doping sanctions [10]. Regulatory status varies by country; what is legal to possess for research in one jurisdiction may be regulated differently in another.
How often do you inject MOTS-c?
This site does not provide dosing information, protocols, or administration schedules for any research compound. Doses in the published animal studies range from approximately 0.5 to 15 mg/kg/day given subcutaneously or intraperitoneally in mice [8][11]; these figures cannot be meaningfully extrapolated to humans, and no validated human dose, route, or schedule has been established in clinical trials [9][10]. Any reader considering use of any research compound should be aware that MOTS-c is not approved for human use, has unknown human pharmacokinetics, and is prohibited in sport.
How do NAD+ and MOTS-c relate to each other?
Both molecules are connected to mitochondrial function and cellular energy metabolism, but through different mechanisms and at very different stages of human evidence. NAD+ is the cell's central redox coenzyme — consumed and recycled in energy metabolism — and its decline with age is partly driven by the NAD-consuming ectoenzyme CD38 rising over time [6]. MOTS-c is a peptide signal that the mitochondrion itself makes and releases, which then activates AMPK in the cytoplasm and regulates nuclear gene expression under stress [12]. One can think of NAD+ as the fuel gauge and MOTS-c as a distress signal: both measure and respond to mitochondrial state, but via different molecular vocabularies. Neither interacts with the other at a mechanistic level documented in the current literature.
What is the difference between NAD+ and NMN?
NAD+ is the active coenzyme — the molecule that cells use directly for energy transfer and enzyme signaling. NMN (nicotinamide mononucleotide) is a precursor: one step earlier in the biosynthesis pathway. When you take oral NMN, it enters the NAD+ salvage pathway in cells and is converted to NAD+. The distinction matters because oral NAD+ itself is not efficiently taken up by cells intact — so NMN (and NR, nicotinamide riboside) are the forms most studies actually test [2][5]. NMN's regulatory status is more complicated: the FDA has taken the position that NMN was investigated as a drug, which may exclude it from the dietary-supplement definition, creating uncertainty in the marketplace [1].